As of 2024-09-19, the Relative Valuation of Tonix Pharmaceuticals Holding Corp (TNXP) is (215.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.15 USD, the upside of Tonix Pharmaceuticals Holding Corp based on Relative Valuation is -148547.5%.
The range of the Relative Valuation is (196.43) - (153.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.0x - 57.2x | 43.1x |
| Forward P/E multiples | 18.4x - 22.6x | 20.5x |
| Fair Price | (196.43) - (153.08) | (215.40) |
| Upside | -135476.6% - -105600.4% | -148547.5% |
| Date | P/E |
| 2024-09-19 | -0.02 |
| 2024-09-18 | -0.02 |
| 2024-09-17 | -0.02 |
| 2024-09-16 | -0.02 |
| 2024-09-13 | -0.02 |
| 2024-09-12 | -0.02 |
| 2024-09-11 | -0.02 |
| 2024-09-10 | -0.02 |
| 2024-09-09 | -0.02 |
| 2024-09-06 | -0.02 |
| 2024-09-05 | -0.02 |
| 2024-09-04 | -0.02 |
| 2024-09-03 | -0.02 |
| 2024-08-30 | -0.03 |
| 2024-08-29 | -0.04 |
| 2024-08-28 | -0.04 |
| 2024-08-27 | -0.05 |
| 2024-08-26 | -0.06 |
| 2024-08-23 | -0.05 |
| 2024-08-22 | -0.05 |
| 2024-08-21 | -0.05 |
| 2024-08-20 | -0.06 |
| 2024-08-19 | -0.07 |
| 2024-08-16 | -0.07 |
| 2024-08-15 | -0.07 |
| 2024-08-14 | -0.07 |
| 2024-08-13 | -0.07 |
| 2024-08-12 | -0.08 |
| 2024-08-09 | -0.07 |
| 2024-08-08 | -0.07 |
| 2024-08-07 | -0.07 |
| 2024-08-06 | -0.07 |
| 2024-08-05 | -0.07 |
| 2024-08-02 | -0.07 |
| 2024-08-01 | -0.08 |
| 2024-07-31 | -0.07 |
| 2024-07-30 | -0.08 |
| 2024-07-29 | -0.08 |
| 2024-07-26 | -0.08 |
| 2024-07-25 | -0.09 |
| 2024-07-24 | -0.08 |
| 2024-07-23 | -0.08 |
| 2024-07-22 | -0.08 |
| 2024-07-19 | -0.08 |
| 2024-07-18 | -0.08 |
| 2024-07-17 | -0.09 |
| 2024-07-16 | -0.09 |
| 2024-07-15 | -0.09 |
| 2024-07-12 | -0.09 |
| 2024-07-11 | -0.09 |